Loading…
Sakar Healthcare (SAKAR)₹1,029+2.43%Pharmaceuticals
At the end of the Sep 2026 quarter, Sakar Healthcare's shareholders were: promoters 51.75%, FIIs 12.38%, DIIs 11.93%, public 23.94%. Promoter holding is down 0.82 percentage points from 52.57% a quarter earlier. FII holding is down 0.97 percentage points from 13.35% a year earlier. 0.00% of promoter shares were pledged. It had 19,533 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.20% | 53.20% | 53.20% | 53.20% | 53.63% | 53.63% | 52.91% | 52.91% | 52.91% | 52.91% | 52.57% | 51.75% |
| FIIs | 13.80% | 13.56% | 13.56% | 13.46% | 13.62% | 13.65% | 13.45% | 13.35% | 13.09% | 12.98% | 12.17% | 12.38% |
| DIIs | 10.63% | 10.63% | 10.63% | 10.63% | 10.89% | 10.98% | 11.26% | 11.44% | 11.37% | 11.33% | 11.38% | 11.93% |
| Public | 22.37% | 22.61% | 22.61% | 22.71% | 21.86% | 21.74% | 22.38% | 22.30% | 22.63% | 22.78% | 23.88% | 23.94% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,999 | 7,384 | 7,311 | 7,865 | 8,596 | 8,606 | 8,113 | 7,563 | 7,067 | 9,577 | 14,730 | 19,533 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Sanjay S Shah | Promoter | 45.01% | 0.00 |
| Tata Capital Healthcare Fund II | DII | 10.37% | 0.00 |
| Hbm Healthcare Investments (Cayman) Ltd | FII | 6.69% | 0.00 |
| Shah Aarsh | Promoter | 5.62% | −0.73 |
| Cobra India (Mauritius) Limited | FII | 3.48% | −0.45 |
| Ritaben Shah | Promoter | 1.11% | 0.00 |
| Shah Ayushi | Promoter | 0.02% | −0.09 |
Promoters held 51.75% of Sakar Healthcare at the end of the Sep 2026 quarter, down 1.16 percentage points from 52.91% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 12.38% (up 0.21 percentage points from 12.17% a quarter earlier) and domestic institutions (DIIs) held 11.93% (up 0.55 percentage points from 11.38% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Sakar Healthcare had 19,533 shareholders at the end of the Sep 2026 quarter, against 7,563 a year earlier.
Tata Capital Healthcare Fund II (DII) held 10.37% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.